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Abstract. Agile methodologies such as XP and Scrum are founded upon the 
four values and twelve principles of agile software development. A software 
development project is only considered to be truly agile if these values and 
principles are followed. However, software developed for use in medical 
devices must be regulatory compliant and this can make the process of 
following a single agile methodology such as XP difficult to achieve. This 
paper outlines how we identified the barriers to agile adoption in the medical 
device software domain through performing a survey. These barriers include: 
lack of documentation; maintaining traceability; regulatory compliance; lack of 
up front planning and the process of managing multiple releases.  Based on this 
research recommendations are also made as to how these barriers can be 
overcome. 
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1   Introduction 
Software is playing an increasingly important role in healthcare [1]. As the reliance 
on this software is increasing, regulatory controls are evolving to ensure the safe and 
reliable performance of medical devices, to prevent harm to patients, clinicians and 
third parties. 
Software is developed in accordance with a customer’s requirements. Software 
used as a medical device or as part of a medical device must also be developed in 
accordance with the regulatory requirements of the region in which the device is 
being marketed [2]. The generic software development industry has benefited from 
adopting agile practices [3]. These practices are procedures defined as being highly 
effective and efficient [4] such as  sprint planning, an open office space, daily 
meetings and product backlogs from Scrum, these have the added benefit of being 
more cost effective [5]. However, there is a low rate of agile adoption amongst safety 
critical software developers [6]. The reasons for this are still being investigated.   This 
paper presents research performed to identify the barriers to adopting agile practices 
when developing medical device software.  
As part of this research, a survey was conducted amongst medical device 
software development organisations in Ireland. This paper also provides 
recommendations as to how these barriers may be overcome.  
The remainder of this paper is structured as follows; in section 2, we present the 
challenges faced by medical device software developers. In section 3, we outline the 
survey conducted and present the results. In section 4, we examine each of the 
barriers identified in section 3 and recommendations are presented as to how these 
barriers can be overcome. Finally, in section 5, we present our conclusions and 
outline how this work will contribute to future research. 
2   Challenges to Developing Medical Device Software 
Software developed for use as a medical device or as part of a medical device in 
Europe must conform to the latest amendment to the Medical Device Directive 
(MDD)  2007/47/EC [7] and the guidance of the associated MED DEV [8] document. 
Software developed as a medical device or part of a medical device in the US must 
conform to the FDA 21 CFR Part 820  [9] Quality System Regulations and 
conformance is recommended to one or more of the following Food and Drug 
Administration (FDA) guidance documents: 
 
• General Principles of Software Validation (GPSV) [10]; 
• Medical Device Data Systems Rule [11]; 
• Guidance for the Content of Premarket Submissions for Software Contained in 
Medical Devices [12]; 
• Draft Guidance for Industry and Food and Drug Administration - Mobile Device 
Applications [13]; 
• Guidance for Industry, FDA Reviewers and Compliance on Off-The-Shelf 
Software use in Medical Devices [14]. 
 
Both the US and European regulations dictate what information a medical device 
software development organisation must produce in order to achieve regulatory 
conformance.  However, these guidelines do not mandate the usage of a specific 
lifecycle to produce this necessary information. IEC 62304:2006 – Medical Device 
Software – Software life cycle processes [15] is harmonised with the MDD [16] and 
is approved for use by the FDA.  IEC 62304 also does not mandate the usage of a 
specific lifecycle. 
Research conducted at Cochlear [17] , Abbott Diagnostics [18], Medtronic [19] 
and a Danish Pharmaceutical Company [20] revealed that medical device software 
developers are actively seeking an alternative to traditional plan driven 
methodologies. These case studies revealed that following agile practices can resolve 
problems associated with plan driven software development.  
 
 
 
 
3   Barriers to Agile Adoption 
As part of their on-going research the authors performed a survey of Irish medical 
device software development organisations. Twenty medical device software 
development organisations were surveyed with multiple responses being received 
from each organisation. The survey revealed that 100% of the respondents who are 
currently marketing medical device software are developing it for use in Europe. In 
addition, 79% of these are also developing medical device software for use in the US. 
The survey identified that 50% of the organisations are developing software in 
accordance with the V-Model.  An important finding was that another 25% of the 
organisations are developing medical device software in accordance with agile 
practices. The remaining 25% of organizations are developing software in accordance 
with other development lifecycles such as the Waterfall, and Iterative & Incremental 
approaches. Participants were asked as part of this survey, to identify the barriers to 
adopting agile practices when developing medical device software. The following 
issues were identified by participants as barriers: 
 
• Lack of Documentation; 
• Traceability Issues; 
• Regulatory Compliance; 
• Lack of Up-Front planning; 
• Managing Multiple Releases. 
4   Overcoming Identified Barriers  
Five barriers to agile adoption have been identified through the survey as outlined in 
section 3. Each of these barriers was examined and recommendations made as to how 
these barriers may be overcome. 
4.1   Lack of Documentation 
The Agile Manifesto [21] has four key values. One of these values is “Working 
Software over Comprehensive Documentation”. This value would appear to be a 
direct contradiction of the regulatory requirements. The FDA regulations require a 
medical device software development organisation to fully document requirements 
prior to development   [22]. However, Robert Martin, one of the authors of the Agile 
Manifesto  states [21]; 
 
“Produce no document unless it’s immediate and significant”. 
 
In terms of achieving regulatory compliance, documentation is significant and as such 
it would still be produced when following agile practices. Research conducted by 
Berard [23] examined the misconceptions regarding documentation and agile software 
development. Agile software developers deliver what is requested by the customer. 
Simply put if a customer/regulatory body requires documentation from an agile 
development team there are no barriers in place to prevent the team from producing 
this documentation whilst still following agile practices.   
4.2   Traceability Issues 
In order for medical device software development organisations to achieve regulatory 
approval they must provide evidence of traceability from the requirements 
specification to each stage of the development process. The FDA General Principles 
of Software Validation (GPSV) [10] document mandates that code must be linked to 
requirements and test cases. Using agile practices, requirements are not fixed before 
development begins and during development changes to requirements are welcomed. 
However, once the requirements specifications and changes to the requirements 
specifications are fully documented, traceability can still be maintained. The FDA 
General Principles of Software Validation state; 
 
 “Most software development models will be iterative. This is likely to result in several 
versions of both the software requirement specification and the software design 
specification. All approved versions should be archived and controlled in accordance 
with established configuration management procedures”.  
 
This statement acts as evidence that regulatory bodies acknowledge that requirements 
can and do change and this is acceptable as long as configuration management 
procedures are adhered to. This results in requirements that can be used to perform 
traceability. 
Lee et al, [24],  present a tool known as “Echo” which can be used to capture 
requirements as part of an agile development project. This tool provides a mechanism 
to maintain traceability between the requirements and each stage of development 
whilst developing software in accordance with agile practices.  
4.3   Regulatory Compliance 
Regulatory controls and development standards provide guidance in the development 
of a safe and reliable medical device. However, the MDD, the FDA and the IEC 
62304 standard do not enforce the use of a specific software development lifecycle. 
IEC 62304 states; 
 
“(The IEC 62304) standard does not require a particular software 
development life cycle model” 
 
As a caveat to the previous statement, IEC 62304 also states; 
 
“Whichever life cycle is chosen it is necessary to maintain the logical 
dependencies between process outputs” 
 
The FDA GPSV states; 
 
“(the FDA) does not recommend the use of any specific software life cycle model. 
Software developers should establish a software life cycle model that is appropriate 
for their product and organization” 
 
The Association of the Advancement of Medical Instrumentation (AAMI), are 
currently in the process of mapping the principles of the Agile Manifesto to IEC 
62304 [25]. As part of this research by the AAMI, each of the 12 agile principles is 
mapped to a specific stage of development in accordance with IEC 62304. The 
upcoming release of this document will provide evidence that agile practices can be 
followed without jeopardising the process of achieving regulatory approval. 
4.4   Lack of Up-Front Planning 
Plan driven software development lifecycles such as the V-Model place a large 
emphasis on up-front planning. This up-front planning can provide stability and a 
point of reference for a development project [2]. However, up-front planning can be 
difficult to perform following agile practices as requirements changes are welcomed 
and expected in an agile project [21]. Whilst this is the case, before a project begins 
agile practices use techniques such as user stories. These are a form of up-front 
planning [26] and can provide the necessary stability to allow a project to begin.  
4.5   Managing Multiple Releases 
Software projects developed in accordance with agile practices are divided into 
iterations. Agile teams attempt to have a potentially shippable system at the end of 
each iteration [27]. Due to the safety critical nature of medical device software, 
regulatory requirements prohibit medical device software developers from releasing 
unfinished software into a live patient environment without being fully tested [10].  
However, whilst agile teams typically develop a shippable system during each 
iteration, this is not a requirement of agile practices. Agile teams can combine 
components developed during iterations and perform the necessary testing once a 
number of iterations have been completed. The process of managing multiple releases 
can be further improved through using third party software tools which are currently 
available such as “Subversion” [28].  
5   Conclusions and Future Work 
Research into the usage of agile practices when developing medical device software is 
still at an early stage. There have been reported successes of utilising agile practices 
when developing medical device software however, these successes have been 
performed in isolation and are yet to be replicated. 
As a result of the survey outlined in this paper, a number of barriers to agile 
adoption in the development of medical device software have been identified. 
Through examination of the relevant medical device regulatory requirements, 
international standards and guidance documents it may be concluded that none of the 
barriers identified are insurmountable. Each of the barriers were analysed in detail and 
information has been provided as to how these barriers can be addressed. The 
research outlined in this paper is part of a larger study and these results will be used to 
assist with further research into the use of agile practices for medical device software 
development.  
Whilst this research identified the perceived barriers to adopting agile practices 
within medical device companies, further research will identify the critical success 
factors to using agile practices when developing medical device software. The 
research outlined in this paper will also contribute to the development of a software 
development lifecycle for medical device software that will integrate the stability of 
following a plan driven software development lifecycle with agile practices.  
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